Verve Therapeutics Inc (VERV)
6.16
-0.06
(-0.96%)
USD |
NASDAQ |
Apr 26, 11:57
Verve Therapeutics Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
Date | Value |
---|---|
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2022
--
Maximum
Sep 2022
--
Average
--
Median
Sep 2022
Total Long Term Debt (Quarterly) Benchmarks
Acorda Therapeutics Inc | 186.14M |
Eli Lilly and Co | 25.23B |
Intellia Therapeutics Inc | 0.00 |
Beam Therapeutics Inc | 0.00 |
Gritstone Bio Inc | 40.14M |